Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
| Status: | Recruiting |
|---|---|
| Conditions: | Colorectal Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/5/2019 |
| Start Date: | February 2015 |
| End Date: | February 2020 |
| Contact: | Zsofia Stadler, MD |
| Phone: | 646-888-4615 |
The purpose of this study is to understand the role bacteria that normally live in the colon
may play in colorectal cancer risk, in addition to the hereditary risk to colorectal cancer.
The investigators will collect stool specimens as well as additional colon biopsy specimens
during the patient's scheduled colonoscopy procedure. The investigators will also collect a
questionnaire about diet and lifestyle. The samples will be used to study the impact of diet
on naturally-occurring oral and gut bacteria and their influences on human health including
risk of cancer.
may play in colorectal cancer risk, in addition to the hereditary risk to colorectal cancer.
The investigators will collect stool specimens as well as additional colon biopsy specimens
during the patient's scheduled colonoscopy procedure. The investigators will also collect a
questionnaire about diet and lifestyle. The samples will be used to study the impact of diet
on naturally-occurring oral and gut bacteria and their influences on human health including
risk of cancer.
Inclusion Criteria:
- Male or Female age 18 or older
- Hereditary colorectal cancer syndrome with one of the following:
- Lynch syndrome, as defined by the presence of a deleterious germline mutation in
the MLH1, MSH2, MSH6, PMS2 or EPCAM genes
- Other hereditary colonic polyposis syndromes, as defined by the presence of a
deleterious germline mutation in any one of the following polyposis genes (APC,
biallelic MYH, STK11, SMAD4, BMPR1A, or other CRC-risk associated genes at
discretion of PI)
Exclusion Criteria:
- Unable to provide informed consent for testing
- Unable to complete English language questionnaire
- Receiving active chemotherapy
- Having completed active chemotherapy less then 12 months prior to day of scheduled
lower endoscopy
- No infectious or drug induced colitis less then 12 months prior to day of scheduled
lower endoscopy
- No history of inflammatory colitis (Crohn's disease or ulcerative colitis)
We found this trial at
1
site
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Principal Investigator: Zsofia Stadler, MD
Phone: 646-888-4615
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
